296 related articles for article (PubMed ID: 12090811)
41. Arachidonic acid and the brain.
Rapoport SI
J Nutr; 2008 Dec; 138(12):2515-20. PubMed ID: 19022981
[TBL] [Abstract][Full Text] [Related]
42. Does EEG predict response to valproate versus lithium in patients with mania?
Reeves RR; Struve FA; Patrick G
Ann Clin Psychiatry; 2001 Jun; 13(2):69-73. PubMed ID: 11534927
[TBL] [Abstract][Full Text] [Related]
43. [Anticonvulsants in the treatment of bipolar disorder].
Grunze H
Neuropsychiatr; 2007; 21(2):110-20. PubMed ID: 17640497
[TBL] [Abstract][Full Text] [Related]
44. Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients.
Hahn CG; Umapathy ; Wang HY; Koneru R; Levinson DF; Friedman E
J Psychiatr Res; 2005 Jul; 39(4):355-63. PubMed ID: 16044535
[TBL] [Abstract][Full Text] [Related]
45. Antimanic activity of minocycline in a GBR12909-induced model of mania in mice: Possible role of antioxidant and neurotrophic mechanisms.
de Queiroz AIG; Chaves Filho AJM; Araújo TDS; Lima CNC; Machado MJS; Carvalho AF; Vasconcelos SMM; de Lucena DF; Quevedo J; Macedo D
J Affect Disord; 2018 Jan; 225():40-51. PubMed ID: 28783519
[TBL] [Abstract][Full Text] [Related]
46. [Lithium and anticonvulsants in bipolar depression].
Samalin L; Nourry A; Llorca PM
Encephale; 2011 Dec; 37 Suppl 3():S203-8. PubMed ID: 22212876
[TBL] [Abstract][Full Text] [Related]
47. Non-lithium treatment for bipolar disorder.
Post RM
J Clin Psychiatry; 1990 Aug; 51 Suppl():9-16; discussion 17-9. PubMed ID: 2116406
[TBL] [Abstract][Full Text] [Related]
48. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder.
Kowatch RA; Suppes T; Carmody TJ; Bucci JP; Hume JH; Kromelis M; Emslie GJ; Weinberg WA; Rush AJ
J Am Acad Child Adolesc Psychiatry; 2000 Jun; 39(6):713-20. PubMed ID: 10846305
[TBL] [Abstract][Full Text] [Related]
49. Chronic carbamazepine administration attenuates dopamine D2-like receptor-initiated signaling via arachidonic acid in rat brain.
Basselin M; Chang L; Chen M; Bell JM; Rapoport SI
Neurochem Res; 2008 Jul; 33(7):1373-83. PubMed ID: 18302021
[TBL] [Abstract][Full Text] [Related]
50. How can the mood stabilizer VPA limit both mania and depression?
Cheng L; Lumb M; Polgár L; Mudge AW
Mol Cell Neurosci; 2005 Jun; 29(2):155-61. PubMed ID: 15911340
[TBL] [Abstract][Full Text] [Related]
51. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
[TBL] [Abstract][Full Text] [Related]
52. Predictors of treatment response in bipolar disorders: evidence from clinical and brain imaging studies.
Ketter TA; Wang PW
J Clin Psychiatry; 2002; 63 Suppl 3():21-5. PubMed ID: 11908918
[TBL] [Abstract][Full Text] [Related]
53. Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?
Li X; Ketter TA; Frye MA
J Affect Disord; 2002 May; 69(1-3):1-14. PubMed ID: 12103447
[TBL] [Abstract][Full Text] [Related]
54. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
Munch G; Godart N
Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
[TBL] [Abstract][Full Text] [Related]
55. Valnoctamide, which reduces rat brain arachidonic acid turnover, is a potential non-teratogenic valproate substitute to treat bipolar disorder.
Modi HR; Ma K; Chang L; Chen M; Rapoport SI
Psychiatry Res; 2017 Aug; 254():279-283. PubMed ID: 28500975
[TBL] [Abstract][Full Text] [Related]
56. Chronic treatment of human astrocytoma cells with lithium, carbamazepine or valproic acid decreases inositol uptake at high inositol concentrations but increases it at low inositol concentrations.
Wolfson M; Bersudsky Y; Zinger E; Simkin M; Belmaker RH; Hertz L
Brain Res; 2000 Feb; 855(1):158-61. PubMed ID: 10650143
[TBL] [Abstract][Full Text] [Related]
57. Rat brain arachidonic acid metabolism is increased by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide.
Rosenberger TA; Villacreses NE; Hovda JT; Bosetti F; Weerasinghe G; Wine RN; Harry GJ; Rapoport SI
J Neurochem; 2004 Mar; 88(5):1168-78. PubMed ID: 15009672
[TBL] [Abstract][Full Text] [Related]
58. Histone deacetylase inhibitors reverse manic-like behaviors and protect the rat brain from energetic metabolic alterations induced by ouabain.
Lopes-Borges J; Valvassori SS; Varela RB; Tonin PT; Vieira JS; Gonçalves CL; Streck EL; Quevedo J
Pharmacol Biochem Behav; 2015 Jan; 128():89-95. PubMed ID: 25433326
[TBL] [Abstract][Full Text] [Related]
59. Auditory and visual P300 evoked potentials do not predict response to valproate versus lithium in patients with mania.
Reeves RR; Struve FA
Ann Clin Psychiatry; 2005; 17(1):47. PubMed ID: 15941031
[No Abstract] [Full Text] [Related]
60. Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein-2.
Rao JS; Ertley RN; Rapoport SI; Bazinet RP; Lee HJ
J Neurochem; 2007 Sep; 102(6):1918-1927. PubMed ID: 17550430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
